Tagapan, Letty B.

HRN: 24 43 84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/16/2024
01/22/2024
IV
600mg
Q8
Non Healing Wound
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: